Rusan’s API plant in Ankleshwar receives USFDA GMP approval EP News Bureau Jul 22, 2024 Rusan Pharma plans to expand its portfolio with additional APIs, including Apomorphine, Buprenorphine, Naloxone, Naltrexone,…
